Pachychoroid spectrum disease and choriocapillary flow analysis in patients with Cushing disease: an optical coherence tomography angiography study

Purpose To investigate the presence of pachychoroid spectrum disease (PSD) in patients with Cushing disease (CD) and to evaluate subfoveal choroidal thickness (SFCT) and choriocapillary flow using spectral domain OCT (SD-OCT) with the enhanced depth imaging (EDI) and optical coherence tomography ang...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Graefe's archive for clinical and experimental ophthalmology Jg. 260; H. 5; S. 1535 - 1542
Hauptverfasser:	Lassandro, Nicola Vito, Nicolai, Michele, Arnaldi, Giorgio, Franceschi, Alessandro, Pelliccioni, Paolo, Cantini, Luca, Gesuita, Rosaria, Faragalli, Andrea, Mariotti, Cesare
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Berlin/Heidelberg Springer Berlin Heidelberg 01.05.2022 Springer Nature B.V
Schlagworte:	Adrenocorticotropic hormone Aneurysm Angiography Choroid - blood supply Cortisol Cushing syndrome Cushing's disease Fluorescein Angiography - methods Hormones Humans Medical imaging Medicine Medicine & Public Health Nervous system diseases Ophthalmology Pituitary Pituitary ACTH Hypersecretion - complications Pituitary ACTH Hypersecretion - diagnosis Retinal Disorders Retrospective Studies Tomography Tomography, Optical Coherence - methods Vascular Diseases Vascularization Choroid Multimodal imaging Cortisol Neovasculopathy Cushing Pachychoroid
ISSN:	0721-832X, 1435-702X, 1435-702X
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Abstract	Purpose To investigate the presence of pachychoroid spectrum disease (PSD) in patients with Cushing disease (CD) and to evaluate subfoveal choroidal thickness (SFCT) and choriocapillary flow using spectral domain OCT (SD-OCT) with the enhanced depth imaging (EDI) and optical coherence tomography angiography (OCT-A). Methods Thirty-two patients with CD and 32 age- and sex-matched healthy volunteers were enrolled in this observational study. All participants had a complete ophthalmic examination including SD-OCT with EDI and OCT-A, and were subjected to the Perceived Stress Scale test (PSS). All patients with CD had hormone test including 24-h urinary-free cortisol (UFC) and plasma adrenocorticotropic hormone (ACTH). We compared SFCT and choriocapillary vessel density (CVD) between the two groups and evaluated the presence of PSD. We investigated the association of hormone level, SFTC, CVD with the presence of CD; the association between the hormone level, SFTC, CVD, the CD disease activity, and duration with the presence of PSD in CD patients; and the association between SFTC and CVD with the hormone level, the CD disease activity, and duration in CD patients. Results Higher values of SFCT and CVD were associated with CD ( β : 0.028, 95% CI: 0.014; 0.041; β : 0.912, 95%CI: 0.205; 1.62, respectively). Twelve patients with CD (37.5%) reported a PSD in at least one eye, whereas no subject was found in control group ( p < 0.001); in particular, 11 CD patients (34%) presented pachychoroid pigment epitheliopathy (PPE) and 1 CD patient (3%) presented polypoidal choroidal vasculopathy/aneurysmal type 1 neovascularization (PCV/AT1). In patients with CD, a significant positive association between SFCT and PSD was found ( β : 0.010, 95% CI 0.001; 0.019). Conclusion A chronic state of hypercortisolism may have direct implications on the choroid. Patients with CD had higher SFCT values and a significant change in the choriocapillary flow compared to healthy controls. Moreover, PSD was observed only in CD patients.
AbstractList	Abstract PurposeTo investigate the presence of pachychoroid spectrum disease (PSD) in patients with Cushing disease (CD) and to evaluate subfoveal choroidal thickness (SFCT) and choriocapillary flow using spectral domain OCT (SD-OCT) with the enhanced depth imaging (EDI) and optical coherence tomography angiography (OCT-A).MethodsThirty-two patients with CD and 32 age- and sex-matched healthy volunteers were enrolled in this observational study. All participants had a complete ophthalmic examination including SD-OCT with EDI and OCT-A, and were subjected to the Perceived Stress Scale test (PSS). All patients with CD had hormone test including 24-h urinary-free cortisol (UFC) and plasma adrenocorticotropic hormone (ACTH). We compared SFCT and choriocapillary vessel density (CVD) between the two groups and evaluated the presence of PSD. We investigated the association of hormone level, SFTC, CVD with the presence of CD; the association between the hormone level, SFTC, CVD, the CD disease activity, and duration with the presence of PSD in CD patients; and the association between SFTC and CVD with the hormone level, the CD disease activity, and duration in CD patients.ResultsHigher values of SFCT and CVD were associated with CD (β: 0.028, 95% CI: 0.014; 0.041; β: 0.912, 95%CI: 0.205; 1.62, respectively). Twelve patients with CD (37.5%) reported a PSD in at least one eye, whereas no subject was found in control group (p < 0.001); in particular, 11 CD patients (34%) presented pachychoroid pigment epitheliopathy (PPE) and 1 CD patient (3%) presented polypoidal choroidal vasculopathy/aneurysmal type 1 neovascularization (PCV/AT1). In patients with CD, a significant positive association between SFCT and PSD was found (β: 0.010, 95% CI 0.001; 0.019).ConclusionA chronic state of hypercortisolism may have direct implications on the choroid. Patients with CD had higher SFCT values and a significant change in the choriocapillary flow compared to healthy controls. Moreover, PSD was observed only in CD patients. To investigate the presence of pachychoroid spectrum disease (PSD) in patients with Cushing disease (CD) and to evaluate subfoveal choroidal thickness (SFCT) and choriocapillary flow using spectral domain OCT (SD-OCT) with the enhanced depth imaging (EDI) and optical coherence tomography angiography (OCT-A). Thirty-two patients with CD and 32 age- and sex-matched healthy volunteers were enrolled in this observational study. All participants had a complete ophthalmic examination including SD-OCT with EDI and OCT-A, and were subjected to the Perceived Stress Scale test (PSS). All patients with CD had hormone test including 24-h urinary-free cortisol (UFC) and plasma adrenocorticotropic hormone (ACTH). We compared SFCT and choriocapillary vessel density (CVD) between the two groups and evaluated the presence of PSD. We investigated the association of hormone level, SFTC, CVD with the presence of CD; the association between the hormone level, SFTC, CVD, the CD disease activity, and duration with the presence of PSD in CD patients; and the association between SFTC and CVD with the hormone level, the CD disease activity, and duration in CD patients. Higher values of SFCT and CVD were associated with CD (β: 0.028, 95% CI: 0.014; 0.041; β: 0.912, 95%CI: 0.205; 1.62, respectively). Twelve patients with CD (37.5%) reported a PSD in at least one eye, whereas no subject was found in control group (p < 0.001); in particular, 11 CD patients (34%) presented pachychoroid pigment epitheliopathy (PPE) and 1 CD patient (3%) presented polypoidal choroidal vasculopathy/aneurysmal type 1 neovascularization (PCV/AT1). In patients with CD, a significant positive association between SFCT and PSD was found (β: 0.010, 95% CI 0.001; 0.019). A chronic state of hypercortisolism may have direct implications on the choroid. Patients with CD had higher SFCT values and a significant change in the choriocapillary flow compared to healthy controls. Moreover, PSD was observed only in CD patients. To investigate the presence of pachychoroid spectrum disease (PSD) in patients with Cushing disease (CD) and to evaluate subfoveal choroidal thickness (SFCT) and choriocapillary flow using spectral domain OCT (SD-OCT) with the enhanced depth imaging (EDI) and optical coherence tomography angiography (OCT-A).PURPOSETo investigate the presence of pachychoroid spectrum disease (PSD) in patients with Cushing disease (CD) and to evaluate subfoveal choroidal thickness (SFCT) and choriocapillary flow using spectral domain OCT (SD-OCT) with the enhanced depth imaging (EDI) and optical coherence tomography angiography (OCT-A).Thirty-two patients with CD and 32 age- and sex-matched healthy volunteers were enrolled in this observational study. All participants had a complete ophthalmic examination including SD-OCT with EDI and OCT-A, and were subjected to the Perceived Stress Scale test (PSS). All patients with CD had hormone test including 24-h urinary-free cortisol (UFC) and plasma adrenocorticotropic hormone (ACTH). We compared SFCT and choriocapillary vessel density (CVD) between the two groups and evaluated the presence of PSD. We investigated the association of hormone level, SFTC, CVD with the presence of CD; the association between the hormone level, SFTC, CVD, the CD disease activity, and duration with the presence of PSD in CD patients; and the association between SFTC and CVD with the hormone level, the CD disease activity, and duration in CD patients.METHODSThirty-two patients with CD and 32 age- and sex-matched healthy volunteers were enrolled in this observational study. All participants had a complete ophthalmic examination including SD-OCT with EDI and OCT-A, and were subjected to the Perceived Stress Scale test (PSS). All patients with CD had hormone test including 24-h urinary-free cortisol (UFC) and plasma adrenocorticotropic hormone (ACTH). We compared SFCT and choriocapillary vessel density (CVD) between the two groups and evaluated the presence of PSD. We investigated the association of hormone level, SFTC, CVD with the presence of CD; the association between the hormone level, SFTC, CVD, the CD disease activity, and duration with the presence of PSD in CD patients; and the association between SFTC and CVD with the hormone level, the CD disease activity, and duration in CD patients.Higher values of SFCT and CVD were associated with CD (β: 0.028, 95% CI: 0.014; 0.041; β: 0.912, 95%CI: 0.205; 1.62, respectively). Twelve patients with CD (37.5%) reported a PSD in at least one eye, whereas no subject was found in control group (p < 0.001); in particular, 11 CD patients (34%) presented pachychoroid pigment epitheliopathy (PPE) and 1 CD patient (3%) presented polypoidal choroidal vasculopathy/aneurysmal type 1 neovascularization (PCV/AT1). In patients with CD, a significant positive association between SFCT and PSD was found (β: 0.010, 95% CI 0.001; 0.019).RESULTSHigher values of SFCT and CVD were associated with CD (β: 0.028, 95% CI: 0.014; 0.041; β: 0.912, 95%CI: 0.205; 1.62, respectively). Twelve patients with CD (37.5%) reported a PSD in at least one eye, whereas no subject was found in control group (p < 0.001); in particular, 11 CD patients (34%) presented pachychoroid pigment epitheliopathy (PPE) and 1 CD patient (3%) presented polypoidal choroidal vasculopathy/aneurysmal type 1 neovascularization (PCV/AT1). In patients with CD, a significant positive association between SFCT and PSD was found (β: 0.010, 95% CI 0.001; 0.019).A chronic state of hypercortisolism may have direct implications on the choroid. Patients with CD had higher SFCT values and a significant change in the choriocapillary flow compared to healthy controls. Moreover, PSD was observed only in CD patients.CONCLUSIONA chronic state of hypercortisolism may have direct implications on the choroid. Patients with CD had higher SFCT values and a significant change in the choriocapillary flow compared to healthy controls. Moreover, PSD was observed only in CD patients. Purpose To investigate the presence of pachychoroid spectrum disease (PSD) in patients with Cushing disease (CD) and to evaluate subfoveal choroidal thickness (SFCT) and choriocapillary flow using spectral domain OCT (SD-OCT) with the enhanced depth imaging (EDI) and optical coherence tomography angiography (OCT-A). Methods Thirty-two patients with CD and 32 age- and sex-matched healthy volunteers were enrolled in this observational study. All participants had a complete ophthalmic examination including SD-OCT with EDI and OCT-A, and were subjected to the Perceived Stress Scale test (PSS). All patients with CD had hormone test including 24-h urinary-free cortisol (UFC) and plasma adrenocorticotropic hormone (ACTH). We compared SFCT and choriocapillary vessel density (CVD) between the two groups and evaluated the presence of PSD. We investigated the association of hormone level, SFTC, CVD with the presence of CD; the association between the hormone level, SFTC, CVD, the CD disease activity, and duration with the presence of PSD in CD patients; and the association between SFTC and CVD with the hormone level, the CD disease activity, and duration in CD patients. Results Higher values of SFCT and CVD were associated with CD ( β : 0.028, 95% CI: 0.014; 0.041; β : 0.912, 95%CI: 0.205; 1.62, respectively). Twelve patients with CD (37.5%) reported a PSD in at least one eye, whereas no subject was found in control group ( p < 0.001); in particular, 11 CD patients (34%) presented pachychoroid pigment epitheliopathy (PPE) and 1 CD patient (3%) presented polypoidal choroidal vasculopathy/aneurysmal type 1 neovascularization (PCV/AT1). In patients with CD, a significant positive association between SFCT and PSD was found ( β : 0.010, 95% CI 0.001; 0.019). Conclusion A chronic state of hypercortisolism may have direct implications on the choroid. Patients with CD had higher SFCT values and a significant change in the choriocapillary flow compared to healthy controls. Moreover, PSD was observed only in CD patients.
Author	Mariotti, Cesare Franceschi, Alessandro Lassandro, Nicola Vito Faragalli, Andrea Nicolai, Michele Gesuita, Rosaria Arnaldi, Giorgio Pelliccioni, Paolo Cantini, Luca
Author_xml	– sequence: 1 givenname: Nicola Vito surname: Lassandro fullname: Lassandro, Nicola Vito organization: Eye Clinic, AOU Ospedali Riuniti Ancona - Polytechnic University of Marche – sequence: 2 givenname: Michele surname: Nicolai fullname: Nicolai, Michele organization: Eye Clinic, AOU Ospedali Riuniti Ancona - Polytechnic University of Marche – sequence: 3 givenname: Giorgio surname: Arnaldi fullname: Arnaldi, Giorgio organization: Division of Endocrinology, AOU Ospedali Riuniti Ancona - Polytechnic University of Marche – sequence: 4 givenname: Alessandro orcidid: 0000-0001-8867-4488 surname: Franceschi fullname: Franceschi, Alessandro email: a.franceschi.md@gmail.com organization: Eye Clinic, AOU Ospedali Riuniti Ancona - Polytechnic University of Marche – sequence: 5 givenname: Paolo surname: Pelliccioni fullname: Pelliccioni, Paolo organization: Eye Clinic, AOU Ospedali Riuniti Ancona - Polytechnic University of Marche – sequence: 6 givenname: Luca surname: Cantini fullname: Cantini, Luca organization: Clinical Oncology, AOU Ospedali Riuniti Ancona - Polytechnic University of Marche – sequence: 7 givenname: Rosaria surname: Gesuita fullname: Gesuita, Rosaria organization: Center of Epidemiology, Biostatistics and Medical Information Technology, Polytechnic University of Marche – sequence: 8 givenname: Andrea surname: Faragalli fullname: Faragalli, Andrea organization: Center of Epidemiology, Biostatistics and Medical Information Technology, Polytechnic University of Marche – sequence: 9 givenname: Cesare surname: Mariotti fullname: Mariotti, Cesare organization: Eye Clinic, AOU Ospedali Riuniti Ancona - Polytechnic University of Marche
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/35067771$$D View this record in MEDLINE/PubMed
BookMark	eNp9kc1q3DAUhUVJaSY_L9BFEXSTjVtJliy3uzI0aSHQLrLITsjS9VjBllxJJvg5-sLVZDIUsggIJDjfuVydc4ZOfPCA0HtKPlFC5OdECKeyIoxWRAjGK_YGbSivRSUJuz9BGyKL1Nbs_hSdpfRACl8L-g6d1oI0Ukq6QX9_azOsZggxOIvTDCbHZcLWJdAJsPYW70UXjJ7dOOq44n4Mj0XQ45pcws7jWWcHPif86PKAt0sanN8dR3wtKA5zdkaP2IQBIngDOIcp7KKeh7XoO3d8p7zY9QK97fWY4PL5Pkd319_vtj-q2183P7ffbitTS5ErbbrWEM4I64gBaQ3tGkl1R0kDmkva2R4Yo9ZCSQt621EQutMtpcLW5Zyjq8PYOYY_C6SsJpcMlE96CEtSrGGMt0TytqAfX6APYYklgj3Fv7RcNFwU6sMztXQTWDVHN5XA1DHtArQHwMSQUoReGZdLeMHnqN2oKFH7YtWhWFWKVU_FKlas7IX1OP1VU30wpQL7HcT_a7_i-gfRFLlc
CitedBy_id	crossref_primary_10_3390_jcm11154437 crossref_primary_10_1186_s40662_025_00441_5
Cites_doi	10.1126/science.7123248 10.4158/EP12389.CR 10.1097/IAE.0000000000001198 10.1016/j.oret.2019.08.002 10.1016/j.preteyeres.2015.05.003 10.1097/IAE.0000000000002051 10.1097/IAE.0b013e3182953df4 10.1016/S0161-6420(02)01975-9 10.1016/j.ophtha.2012.07.048 10.1016/j.survophthal.2012.12.001 10.1136/bjo.81.11.962 10.3389/fendo.2016.00154 10.1111/aos.14664 10.1177/1120672119887095 10.1097/IAE.0000000000000742 10.1038/s41433-018-0158-4 10.1001/archopht.1993.01090090081024 10.1097/IAE.0b013e318297a07a 10.1016/S0039-6257(02)00338-7 10.1097/IAE.0b013e31823ff9a6 10.1016/j.ajo.2015.08.028 10.1167/iovs.15-17140 10.1002/j.1550-8528.1994.tb00097.x 10.1007/s10792-017-0666-4 10.3389/fpsyg.2018.00037 10.1038/s41598-019-42052-w 10.1210/jc.2008-0125 10.1097/IAE.0000000000001956 10.1172/JCI61427
ContentType	Journal Article
Copyright	The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021.
Copyright_xml	– notice: The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021 – notice: 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. – notice: The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021.
DBID	AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7TK 7X7 7XB 88E 8AO 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8
DOI	10.1007/s00417-021-05524-2
DatabaseName	CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Neurosciences Abstracts Health & Medical Collection (ProQuest) ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central ProQuest One ProQuest Health & Medical Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic
DatabaseTitleList	ProQuest One Academic Middle East (New) MEDLINE MEDLINE - Academic
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1435-702X
EndPage	1542
ExternalDocumentID	35067771 10_1007_s00417_021_05524_2
Genre	Journal Article Observational Study
GroupedDBID	--- -53 -5E -5G -BR -EM -Y2 -~C .55 .86 .VR 06C 06D 0R~ 0VY 199 1N0 2.D 203 28- 29I 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 3O- 3V. 4.4 406 408 409 40D 40E 53G 5QI 5VS 67Z 6NX 78A 7X7 88E 8AO 8FI 8FJ 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABLJU ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACUDM ACZOJ ADBBV ADHIR ADINQ ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFEXP AFKRA AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AOCGG ARMRJ AXYYD AZFZN B-. BA0 BBWZM BDATZ BENPR BGNMA BPHCQ BSONS BVXVI CAG CCPQU COF CSCUP DDRTE DL5 DNIVK DPUIP EBD EBLON EBS EIOEI EJD EMOBN EN4 ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GRRUI GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ IMOTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH LAS LLZTM M1P M4Y MA- N2Q N9A NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM P19 P2P P9S PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R89 R9I RHV RIG RNI ROL RPX RRX RSV RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 X7M YLTOR Z45 Z7U Z81 Z82 Z83 Z87 Z8O Z8U Z8V Z8W Z91 ZMTXR ZOVNA ~EX AAPKM AAYXX ABBRH ABDBE ABFSG ABRTQ ACSTC ADHKG AEZWR AFDZB AFFHD AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT PJZUB PPXIY CGR CUY CVF ECM EIF NPM 7TK 7XB 8FK K9. PKEHL PQEST PQUKI PRINS 7X8 PUEGO
ID	FETCH-LOGICAL-c375t-acb8c04202b0ce7dc1b671ab106ea471bdfe221dde100efdb1e5aba8115d35d3
IEDL.DBID	RSV
ISICitedReferencesCount	2
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000745765000003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	0721-832X 1435-702X
IngestDate	Thu Oct 02 11:14:50 EDT 2025 Wed Nov 05 02:22:10 EST 2025 Wed Feb 19 02:27:34 EST 2025 Sat Nov 29 03:20:05 EST 2025 Tue Nov 18 21:13:26 EST 2025 Fri Feb 21 02:46:15 EST 2025
IsPeerReviewed	true
IsScholarly	true
Issue	5
Keywords	Choroid Multimodal imaging Cortisol Neovasculopathy Cushing Pachychoroid
Language	English
License	2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c375t-acb8c04202b0ce7dc1b671ab106ea471bdfe221dde100efdb1e5aba8115d35d3
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Undefined-3
ORCID	0000-0001-8867-4488
PMID	35067771
PQID	2649845645
PQPubID	48614
PageCount	8
ParticipantIDs	proquest_miscellaneous_2622480748 proquest_journals_2649845645 pubmed_primary_35067771 crossref_citationtrail_10_1007_s00417_021_05524_2 crossref_primary_10_1007_s00417_021_05524_2 springer_journals_10_1007_s00417_021_05524_2
PublicationCentury	2000
PublicationDate	2022-05-01
PublicationDateYYYYMMDD	2022-05-01
PublicationDate_xml	– month: 05 year: 2022 text: 2022-05-01 day: 01
PublicationDecade	2020
PublicationPlace	Berlin/Heidelberg
PublicationPlace_xml	– name: Berlin/Heidelberg – name: Germany – name: Heidelberg
PublicationSubtitle	Incorporating German Journal of Ophthalmology
PublicationTitle	Graefe's archive for clinical and experimental ophthalmology
PublicationTitleAbbrev	Graefes Arch Clin Exp Ophthalmol
PublicationTitleAlternate	Graefes Arch Clin Exp Ophthalmol
PublicationYear	2022
Publisher	Springer Berlin Heidelberg Springer Nature B.V
Publisher_xml	– name: Springer Berlin Heidelberg – name: Springer Nature B.V
References	Dansingani, Balaratnasingam, Naysan, Freund (CR24) 2016; 36 Dansingani, Balaratnasingam, Klufas (CR25) 2015; 160 Warrow, Hoang, Freund (CR1) 2013; 33 Daruich, Matet, Dirani (CR10) 2015; 48 Giovansili, Belange, Affortit (CR20) 2013; 19 Siedlecki, Schworm, Priglinger (CR23) 2019; 3 Bouzas, Scott, Mastorakos (CR19) 1993; 111 Bouzas, Karadimas, Pournaras (CR7) 2002; 47 Gal-Or, Dansingani, Sebrow (CR26) 2018; 38 Wang, Chen, Yang (CR13) 2019; 39 Cheung, Lee, Koizumi (CR2) 2019; 33 Demirel, Değirmenci, Batıoğlu, Özmert (CR30) 2021; 31 Mrejen, Spaide (CR4) 2013; 58 Garg, Dada, Talwar, Biswas (CR6) 1997; 81 Abalem, Machado, Veloso Dos Santos (CR11) 2016; 7 Yannuzzi (CR21) 2012; 32 Akkaya (CR29) 2018; 38 Teussink, Breukink, Van Grinsven (CR28) 2015; 56 Eymard, Gerardy, Bouys (CR14) 2021; 99 Bousquet, Beydoun, Zhao (CR9) 2013; 33 Öner, Deliktas, Arda (CR16) 2014; 22 Bin, Xu, Jonas (CR3) 2013; 120 Karaca, Karaca, Kahraman (CR12) 2017; 37 Williams, Lane, Kuhn (CR22) 1982; 218 Vallejo, Vallejo-Slocker, Fernández-Abascal, Mañanes (CR18) 2018; 9 Haimovici, Rumelt, Melby (CR5) 2003; 110 Cushing (CR15) 1994; 2 Baek, Kook, Lee (CR27) 2019; 9 Zhao, Célérier, Bousquet (CR8) 2012; 122 Nieman, Biller, Findling (CR17) 2008; 93 MA Vallejo (5524_CR18) 2018; 9 P Eymard (5524_CR14) 2021; 99 J Siedlecki (5524_CR23) 2019; 3 KK Dansingani (5524_CR25) 2015; 160 S Akkaya (5524_CR29) 2018; 38 MF Abalem (5524_CR11) 2016; 7 J Baek (5524_CR27) 2019; 9 WW Bin (5524_CR3) 2013; 120 S Mrejen (5524_CR4) 2013; 58 O Gal-Or (5524_CR26) 2018; 38 DJ Warrow (5524_CR1) 2013; 33 H Cushing (5524_CR15) 1994; 2 S Demirel (5524_CR30) 2021; 31 A Öner (5524_CR16) 2014; 22 SP Garg (5524_CR6) 1997; 81 LK Nieman (5524_CR17) 2008; 93 LA Yannuzzi (5524_CR21) 2012; 32 CMG Cheung (5524_CR2) 2019; 33 KK Dansingani (5524_CR24) 2016; 36 EA Bouzas (5524_CR7) 2002; 47 C Karaca (5524_CR12) 2017; 37 I Giovansili (5524_CR20) 2013; 19 M Zhao (5524_CR8) 2012; 122 E Wang (5524_CR13) 2019; 39 A Daruich (5524_CR10) 2015; 48 EA Bouzas (5524_CR19) 1993; 111 RB Williams (5524_CR22) 1982; 218 R Haimovici (5524_CR5) 2003; 110 E Bousquet (5524_CR9) 2013; 33 MM Teussink (5524_CR28) 2015; 56
References_xml	– volume: 218 start-page: 483 issue: 4571 year: 1982 end-page: 485 ident: CR22 article-title: Type A behavior and elevated physiological and neuroendocrine responses to cognitive tasks publication-title: Science (80- ) doi: 10.1126/science.7123248 – volume: 19 start-page: e129 issue: 5 year: 2013 end-page: 33 ident: CR20 article-title: Cushing disease revealed by bilateral atypical central serous chorioretinopathy: case report publication-title: Endocr Pract doi: 10.4158/EP12389.CR – volume: 22 start-page: 204 issue: 3 year: 2014 end-page: 208 ident: CR16 article-title: Diurnal variation of central choroidal thickness in healthy Turkish subjects measured by spectral-domain optical coherence tomography publication-title: Retina-Vitreus – volume: 37 start-page: 536 issue: 3 year: 2017 end-page: 543 ident: CR12 article-title: Is there a role of acth in increased choroidal thickness in cushing syndrome? publication-title: Retina doi: 10.1097/IAE.0000000000001198 – volume: 3 start-page: 1013 issue: 12 year: 2019 end-page: 1015 ident: CR23 article-title: The pachychoroid disease spectrum-and the need for a uniform classification system publication-title: Ophthalmol Retin doi: 10.1016/j.oret.2019.08.002 – volume: 48 start-page: 82 year: 2015 end-page: 118 ident: CR10 article-title: Central serous chorioretinopathy: recent findings and new physiopathology hypothesis publication-title: Prog Retin Eye Res doi: 10.1016/j.preteyeres.2015.05.003 – volume: 38 start-page: 1984 issue: 10 year: 2018 end-page: 1992 ident: CR26 article-title: Inner choroidal flow signal attenuation in pachychoroid disease: Optical coherence tomography angiography publication-title: Retina doi: 10.1097/IAE.0000000000002051 – volume: 33 start-page: 1659 issue: 8 year: 2013 end-page: 1672 ident: CR1 article-title: Pachychoroid pigment epitheliopathy publication-title: Retina doi: 10.1097/IAE.0b013e3182953df4 – volume: 110 start-page: 698 issue: 4 year: 2003 end-page: 703 ident: CR5 article-title: Endocrine abnormalities in patients with central serous chorioretinopathy publication-title: Ophthalmology doi: 10.1016/S0161-6420(02)01975-9 – volume: 120 start-page: 175 issue: 1 year: 2013 end-page: 180 ident: CR3 article-title: Subfoveal choroidal thickness: the Beijing eye study publication-title: Ophthalmology doi: 10.1016/j.ophtha.2012.07.048 – volume: 58 start-page: 387 issue: 5 year: 2013 end-page: 429 ident: CR4 article-title: Optical coherence tomography: imaging of the choroid and beyond publication-title: Surv Ophthalmol doi: 10.1016/j.survophthal.2012.12.001 – volume: 81 start-page: 962 issue: 11 year: 1997 end-page: 964 ident: CR6 article-title: Endogenous cortisol profile in patients with central serous chorioretinopathy publication-title: Br J Ophthalmol doi: 10.1136/bjo.81.11.962 – volume: 7 start-page: 154 year: 2016 ident: CR11 article-title: Choroidal and retinal abnormalities by optical coherence tomography in endogenous Cushing’s syndrome publication-title: Front Endocrinol doi: 10.3389/fendo.2016.00154 – volume: 99 start-page: 533 issue: 5 year: 2021 end-page: 537 ident: CR14 article-title: Choroidal imaging in patients with Cushing syndrome publication-title: Acta Ophthalmol doi: 10.1111/aos.14664 – volume: 31 start-page: 184 issue: 1 year: 2021 end-page: 193 ident: CR30 article-title: Evaluation of the choroidal features in pachychoroid spectrum diseases by optical coherence tomography and optical coherence tomography angiography publication-title: Eur J Ophthalmol doi: 10.1177/1120672119887095 – volume: 36 start-page: 499 issue: 3 year: 2016 end-page: 516 ident: CR24 article-title: En face imaging of pachychoroid spectrum disorders with swept-source optical coherence tomography publication-title: Retina doi: 10.1097/IAE.0000000000000742 – volume: 33 start-page: 14 issue: 1 year: 2019 end-page: 33 ident: CR2 article-title: Pachychoroid disease publication-title: Eye doi: 10.1038/s41433-018-0158-4 – volume: 111 start-page: 1229 issue: 9 year: 1993 end-page: 1233 ident: CR19 article-title: Central serous chorioretinopathy in endogenous hypercortisolism publication-title: Arch Ophthalmol doi: 10.1001/archopht.1993.01090090081024 – volume: 33 start-page: 2096 issue: 10 year: 2013 end-page: 2102 ident: CR9 article-title: Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy: a pilot study publication-title: Retina doi: 10.1097/IAE.0b013e318297a07a – volume: 47 start-page: 431 issue: 5 year: 2002 end-page: 448 ident: CR7 article-title: Central serous chorioretinopathy and glucocorticoids publication-title: Surv Ophthalmol doi: 10.1016/S0039-6257(02)00338-7 – volume: 32 start-page: 709 issue: Suppl 1 year: 2012 ident: CR21 article-title: Type A behavior and central serous chorioretinopathy publication-title: Retina doi: 10.1097/IAE.0b013e31823ff9a6 – volume: 160 start-page: 1243 issue: 6 year: 2015 end-page: 1254.e2 ident: CR25 article-title: Optical coherence tomography angiography of shallow irregular pigment epithelial detachments in pachychoroid spectrum disease publication-title: Am J Ophthalmol doi: 10.1016/j.ajo.2015.08.028 – volume: 56 start-page: 5229 issue: 9 year: 2015 end-page: 5237 ident: CR28 article-title: Oct angiography compared to fluorescein and indocyanine green angiography in chronic central serous chorioretinopathy publication-title: Investig Ophthalmol Vis Sci doi: 10.1167/iovs.15-17140 – volume: 2 start-page: 486 issue: 5 year: 1994 end-page: 508 ident: CR15 article-title: The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism) 1932 publication-title: Obes Res doi: 10.1002/j.1550-8528.1994.tb00097.x – volume: 38 start-page: 2239 issue: 5 year: 2018 end-page: 2246 ident: CR29 article-title: Spectrum of pachychoroid diseases publication-title: Int Ophthalmol doi: 10.1007/s10792-017-0666-4 – volume: 9 start-page: 37 year: 2018 ident: CR18 article-title: Determining factors for stress perception assessed with the Perceived Stress Scale (PSS-4) in Spanish and other European samples publication-title: Front Psychol doi: 10.3389/fpsyg.2018.00037 – volume: 9 start-page: 5565 issue: 1 year: 2019 ident: CR27 article-title: Choriocapillaris flow impairments in association with pachyvessel in early stages of pachychoroid publication-title: Sci Rep doi: 10.1038/s41598-019-42052-w – volume: 93 start-page: 1526 issue: 5 year: 2008 end-page: 1540 ident: CR17 article-title: The diagnosis of Cushing’s syndrome: an endocrine society clinical practice guideline publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2008-0125 – volume: 39 start-page: 408 issue: 2 year: 2019 end-page: 414 ident: CR13 article-title: Choroidal thickening and pachychoroid in cushing syndrome: correlation with endogenous cortisol level publication-title: Retina doi: 10.1097/IAE.0000000000001956 – volume: 122 start-page: 2672 issue: 7 year: 2012 end-page: 2679 ident: CR8 article-title: Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy publication-title: J Clin Invest doi: 10.1172/JCI61427 – volume: 56 start-page: 5229 issue: 9 year: 2015 ident: 5524_CR28 publication-title: Investig Ophthalmol Vis Sci doi: 10.1167/iovs.15-17140 – volume: 93 start-page: 1526 issue: 5 year: 2008 ident: 5524_CR17 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2008-0125 – volume: 120 start-page: 175 issue: 1 year: 2013 ident: 5524_CR3 publication-title: Ophthalmology doi: 10.1016/j.ophtha.2012.07.048 – volume: 19 start-page: e129 issue: 5 year: 2013 ident: 5524_CR20 publication-title: Endocr Pract doi: 10.4158/EP12389.CR – volume: 38 start-page: 2239 issue: 5 year: 2018 ident: 5524_CR29 publication-title: Int Ophthalmol doi: 10.1007/s10792-017-0666-4 – volume: 99 start-page: 533 issue: 5 year: 2021 ident: 5524_CR14 publication-title: Acta Ophthalmol doi: 10.1111/aos.14664 – volume: 122 start-page: 2672 issue: 7 year: 2012 ident: 5524_CR8 publication-title: J Clin Invest doi: 10.1172/JCI61427 – volume: 33 start-page: 1659 issue: 8 year: 2013 ident: 5524_CR1 publication-title: Retina doi: 10.1097/IAE.0b013e3182953df4 – volume: 48 start-page: 82 year: 2015 ident: 5524_CR10 publication-title: Prog Retin Eye Res doi: 10.1016/j.preteyeres.2015.05.003 – volume: 7 start-page: 154 year: 2016 ident: 5524_CR11 publication-title: Front Endocrinol doi: 10.3389/fendo.2016.00154 – volume: 32 start-page: 709 issue: Suppl 1 year: 2012 ident: 5524_CR21 publication-title: Retina doi: 10.1097/IAE.0b013e31823ff9a6 – volume: 9 start-page: 5565 issue: 1 year: 2019 ident: 5524_CR27 publication-title: Sci Rep doi: 10.1038/s41598-019-42052-w – volume: 37 start-page: 536 issue: 3 year: 2017 ident: 5524_CR12 publication-title: Retina doi: 10.1097/IAE.0000000000001198 – volume: 9 start-page: 37 year: 2018 ident: 5524_CR18 publication-title: Front Psychol doi: 10.3389/fpsyg.2018.00037 – volume: 39 start-page: 408 issue: 2 year: 2019 ident: 5524_CR13 publication-title: Retina doi: 10.1097/IAE.0000000000001956 – volume: 58 start-page: 387 issue: 5 year: 2013 ident: 5524_CR4 publication-title: Surv Ophthalmol doi: 10.1016/j.survophthal.2012.12.001 – volume: 81 start-page: 962 issue: 11 year: 1997 ident: 5524_CR6 publication-title: Br J Ophthalmol doi: 10.1136/bjo.81.11.962 – volume: 47 start-page: 431 issue: 5 year: 2002 ident: 5524_CR7 publication-title: Surv Ophthalmol doi: 10.1016/S0039-6257(02)00338-7 – volume: 22 start-page: 204 issue: 3 year: 2014 ident: 5524_CR16 publication-title: Retina-Vitreus – volume: 111 start-page: 1229 issue: 9 year: 1993 ident: 5524_CR19 publication-title: Arch Ophthalmol doi: 10.1001/archopht.1993.01090090081024 – volume: 31 start-page: 184 issue: 1 year: 2021 ident: 5524_CR30 publication-title: Eur J Ophthalmol doi: 10.1177/1120672119887095 – volume: 33 start-page: 14 issue: 1 year: 2019 ident: 5524_CR2 publication-title: Eye doi: 10.1038/s41433-018-0158-4 – volume: 36 start-page: 499 issue: 3 year: 2016 ident: 5524_CR24 publication-title: Retina doi: 10.1097/IAE.0000000000000742 – volume: 160 start-page: 1243 issue: 6 year: 2015 ident: 5524_CR25 publication-title: Am J Ophthalmol doi: 10.1016/j.ajo.2015.08.028 – volume: 3 start-page: 1013 issue: 12 year: 2019 ident: 5524_CR23 publication-title: Ophthalmol Retin doi: 10.1016/j.oret.2019.08.002 – volume: 38 start-page: 1984 issue: 10 year: 2018 ident: 5524_CR26 publication-title: Retina doi: 10.1097/IAE.0000000000002051 – volume: 33 start-page: 2096 issue: 10 year: 2013 ident: 5524_CR9 publication-title: Retina doi: 10.1097/IAE.0b013e318297a07a – volume: 2 start-page: 486 issue: 5 year: 1994 ident: 5524_CR15 publication-title: Obes Res doi: 10.1002/j.1550-8528.1994.tb00097.x – volume: 110 start-page: 698 issue: 4 year: 2003 ident: 5524_CR5 publication-title: Ophthalmology doi: 10.1016/S0161-6420(02)01975-9 – volume: 218 start-page: 483 issue: 4571 year: 1982 ident: 5524_CR22 publication-title: Science (80- ) doi: 10.1126/science.7123248
SSID	ssj0004351
Score	2.350467
Snippet	Purpose To investigate the presence of pachychoroid spectrum disease (PSD) in patients with Cushing disease (CD) and to evaluate subfoveal choroidal thickness... To investigate the presence of pachychoroid spectrum disease (PSD) in patients with Cushing disease (CD) and to evaluate subfoveal choroidal thickness (SFCT)... Abstract PurposeTo investigate the presence of pachychoroid spectrum disease (PSD) in patients with Cushing disease (CD) and to evaluate subfoveal choroidal...
SourceID	proquest pubmed crossref springer
SourceType	Aggregation Database Index Database Enrichment Source Publisher
StartPage	1535
SubjectTerms	Adrenocorticotropic hormone Aneurysm Angiography Choroid - blood supply Cortisol Cushing syndrome Cushing's disease Fluorescein Angiography - methods Hormones Humans Medical imaging Medicine Medicine & Public Health Nervous system diseases Ophthalmology Pituitary Pituitary ACTH Hypersecretion - complications Pituitary ACTH Hypersecretion - diagnosis Retinal Disorders Retrospective Studies Tomography Tomography, Optical Coherence - methods Vascular Diseases Vascularization
SummonAdditionalLinks	– databaseName: ProQuest Central dbid: BENPR link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LaxRBEC50I-Il8Z0xUVrwpo3TPW8voiHBgy6LBNnb0K9NBpKZdR8J_g7_sFU9PbtIMBdhDgPV09NQ1VXVVV1fAbxJdDLDc0PJVW4rnurCcR27ioscPTnrTKo9zvaPr8V4XE6n1SQE3JbhWuWgE72itp2hGPl7NNxV6bFPPs5_cuoaRdnV0ELjLuwQUlk6gp3Px-PJ921lZOIbMBIIGEfZnYayGV88R1BTBacrCnGWyZTLv03TDX_zRq7Um6CTvf9d_EPYDc4n-9RLyyO449rHcP9bSK8_gd8TZc5JIS66xjJfhLlYX7KQxGGqtYyIDdq_OXUrWvxis4vuGgk9sglrWhaAWpeMIrzsaO1DXMMUH3Ao6-Y-fs5Md97XGrJVdxmQs5F-1gzvHvr2KZyeHJ8efeGhawM3SZGtuDK6NKgKYqlj4wprhM4LoTSePZ1CU6jtzEkpUK0iG9zMauEypVWJrqlN8HkGo7Zr3T6w3AjhdKXKzKjUxHlpjFBZKqXOM4t-SQRi4FdtAqI5Nda4qDdYzJ7HNfK49jyuZQRvN9_MezyPW0cfDvysw95e1ltmRvB6Q8ZdSakW1bpuTWPQNSKcoTKC5734bH6XZITaV4gI3g3ytJ3832t5cftaDuCBpMoMfxfzEEYoH-4l3DNXq2a5eBX2xR9iMBZe priority: 102 providerName: ProQuest
Title	Pachychoroid spectrum disease and choriocapillary flow analysis in patients with Cushing disease: an optical coherence tomography angiography study
URI	https://link.springer.com/article/10.1007/s00417-021-05524-2 https://www.ncbi.nlm.nih.gov/pubmed/35067771 https://www.proquest.com/docview/2649845645 https://www.proquest.com/docview/2622480748
Volume	260
WOSCitedRecordID	wos000745765000003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVAVX databaseName: SpringerLINK Contemporary 1997-Present customDbUrl: eissn: 1435-702X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0004351 issn: 0721-832X databaseCode: RSV dateStart: 19970101 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Za9wwEB7apJS89G7jNFlU6FsrsHxJzlsbEvKQLEsawr4ZXZsYEnvZI6G_o3-4I1l2KGkLLRhjGFkW8lzSaL4B-JiqdIbrBkFlYUqaKW6pim1JWYGenLE6Ux5n--KEj8diOi0nISls2Z9270OSXlMPyW4OGopTd6QgzvMko6h4N9HcCSeOZ98u7rMhU1900QF_UeTXaUiV-X0fv5qjBz7mg_ioNztHz_9vwC_gWXAzyZeOL17CI9u8gqenIZD-Gn5MpL5yqm_R1ob4dMvF-oaEcA2RjSGOWKOlm7u6RIvvZHbd3iGhwzAhdUMCJOuSuL1ccrD2m1l9F_vYlLRzv1NOdHvVZRWSVXsTMLKRfln3zx7k9g2cHx2eHxzTUJ-B6pTnKyq1EhqFPk5UrC03mqmCM6lwlWklGj1lZjZJGCpQnA87M4rZXCop0Ak1KV5vYaNpG7sNpNCMWVVKkWuZ6bgQWjOZZ0miitygBxIB6_9SpQN2uSuhcV0NqMt-siuc7MpPdpVE8Gl4Z94hd_y19W7_86sgxcsKncVSeLydCD4MZJQ_F1SRjW3Xrg06QQ5RSETwrmOa4XNp7vD5OIvgc88h953_eSw7_9b8PWwlLifDn8LchQ3kF7sHT_Ttql4uRvCYT7m_ixFsfj0cT85GXl5-AprlDjE
linkProvider	Springer Nature
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VgoAL70eggJHgRC1i5-EECSFUqFp1u-phhfZm-bU0Upss-6Dq7-B38B8ZO8muUEVvPSDlEMmOYyXfjMeemW8A3iQ6meC-oaAqtyVNtXBUx66kLEdLzjqT6sCz_W0ghsNiPC6PNuB3nwvjwyp7nRgUtW2MPyN_jwt3WQTuk0_TH9RXjfLe1b6ERguLA3d-hlu2-cf9L_h_33K--3W0s0e7qgLUJCJbUGV0YRCqMdexccIapnPBlMa9kVOoqrWdOM4Zij2LYzexmrlMaVWg6WQTvHDYa3Ad1bjwEWRiLNZpmEmo9ugZxygKyrjL0QmZep7XSlAfDxFnGU8p_3sdvGDcXnDMhvVu9-5_9qXuwZ3OsCafW0m4DxuufgA3D7vQgYfw60iZY6_sZ01lSUgwnS1PSeegIqq2xDdWuLZPfSWm2TmZnDRn2NCytpCqJh0J7Zz402uyswzHd_0QH7AraabBN0BMc9zmUZJFc9qxgmP796q_D7S-j2B0FV_kMWzWTe2eAskNY06XqsiMSk2cF8YwlaWc6zyzaHNFwHp4SNOxtfuiISdyxTMdICURUjJASvII3q2embZcJZf23urhIzu9NZdr7ETwetWMGse7kVTtmqXvg2af51AqInjSonX1uiTzjISCRbDdw3c9-L_n8uzyubyCW3ujw4Ec7A8PnsNt7jNQQszpFmwiVtwLuGF-Lqr57GUQSALyimH9B3BSdDg
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VLap64V26UMBIcAKrsfNGQgjarqhaVitUob1FfoVGapNlH1T9Hfwa_h1jx9kVquitB6QcItlxrOTzzNgz8w3Aq1CGJe4bMioSndNIpobKwOSUJWjJaaMi6Xi2vx2nw2E2HuejNfjd5cLYsMpOJjpBrRtlz8h3UXHnmeM-2S19WMRof_Bh8oPaClLW09qV02ghcmQuL3D7Nnt_uI__-jXng4OTvc_UVxigKkzjORVKZgphG3AZKJNqxWSSMiFxn2QEim2pS8M5QxHAgsCUWjITCykyNKN0iBcOewvWU7Qx4h6sfzoYjr6ukjJDV_vR8o9RXDZjn7Hj8vYsy1VKbXREEMc8ovxvrXjF1L3ipnXab3D3P_5u9-CON7nJx3aN3Ic1Uz-AjS8-qOAh_BoJdWrVwLSpNHGpp9PFOfGuKyJqTWxjhVp_Yms0TS9JedZcYEPL50Kqmnh62hmx59pkb-EO9roh3mFX0kyc14Co5rTNsCTz5tzzhWP796q7d4S_j-DkJr7IFvTqpjbbQBLFmJG5yGIlIhUkmVJMxBHnMok1WmN9YB1UCuV53G05kbNiyUDt4FUgvAoHr4L34c3ymUnLYnJt750OSoWXaLNihaM-vFw2oyyyDiZRm2Zh-6BBaNmVsj48bpG7fF0YW67ClPXhbQfl1eD_nsuT6-fyAjYQzcXx4fDoKWxym5riglF3oIdQMc_gtvo5r2bT5351EihuGNd_AO3tflg
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pachychoroid+spectrum+disease+and+choriocapillary+flow+analysis+in+patients+with+Cushing+disease%3A+an+optical+coherence+tomography+angiography+study&rft.jtitle=Graefe%27s+archive+for+clinical+and+experimental+ophthalmology&rft.au=Lassandro%2C+Nicola+Vito&rft.au=Nicolai%2C+Michele&rft.au=Arnaldi%2C+Giorgio&rft.au=Franceschi%2C+Alessandro&rft.date=2022-05-01&rft.pub=Springer+Berlin+Heidelberg&rft.issn=0721-832X&rft.eissn=1435-702X&rft.volume=260&rft.issue=5&rft.spage=1535&rft.epage=1542&rft_id=info:doi/10.1007%2Fs00417-021-05524-2&rft.externalDocID=10_1007_s00417_021_05524_2
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0721-832X&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0721-832X&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0721-832X&client=summon